Apolipoprotein E Gene Polymorphism in Psoriasis: A Meta-analysis

Archives of Medical Research

Volumn 44, Issue 1, 2013, Pages 46-53

  Han, Yi ^a   Liu, Tong ^a   Lu, Lechun ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E; Meta analysis; Polymorphism; Psoriasis

Indexed keywords

ALLELE; APOLIPOPROTEIN E GENE; ARTICLE; ASIAN; CAUCASIAN; DISEASE PREDISPOSITION; ETHNICITY; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; PSORIASIS; PSORIATIC ARTHRITIS; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

ALLELES; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PSORIASIS; PUBLICATION BIAS;

EID: 84873179473     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.10.009     Document Type: Article

References (40)

1. Naldi L. Inflammatory skin diseases. IV: Psoriasis. The Challenge of Dermato-epidemiology 1997, 175-187. CRC Press, Boca Raton, FL. D.P. Strachan (Ed.).
2. Gelfand J.M., Dommasch E.D., Shin D.B., et al. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009, 129:2411-2418.
3. Qureshi A.A., Choi H.K., Setty A.R., et al. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 2009, 145:379-382.
4. Guideline on clinical investigation of medicinal products indicated for the treatment of psoriasis 2004, European Medicine Agency.
5. Liu Y., Krueger J.G., Bowcock A.M. Psoriasis: genetic associations and immune system changes. Genes Immun 2007, 8:1-12.
6. Veal C.D., Capon F., Allen M.H., et al. Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus. Am J Hum Genet 2002, 71:554-564.
7. Tsunemi Y., Saeki H., Nakamura K., et al. Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 2002, 30:161-166.
8. Park B.S., Park J.S., Lee D.Y., et al. Vitamin D receptor polymorphism is associated with psoriasis. J Invest Dermatol 1999, 112:113-116.
9. Furumoto H., Nakamura K., Imamura T., et al. Association of apolipoprotein allele epsilon 2 with psoriasis vulgaris in Japanese population. Arch Dermatol Res 1997, 289:497-500.
10. Havel R.J., Yamada N., Shames D.M. Role of apolipoprotein E in lipoprotein metabolism. Am Heart J 1987, 113:470-474.
11. Yamada N., Shimano H., Yazaki Y. Role of apolipoprotein E in lipoprotein metabolism and in the process of atherosclerosis. J Atheroscler Thromb 1995, 2(suppl 1):S29-S33.
12. Harris F.M., Tesseur I., Brecht W.J., et al. Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease. J Biol Chem 2004, 279:3862-3868.
13. Tiret L., de Knijff P., Menzel H.J., et al. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb 1994, 14:1617-1624.
14. Feussner G., Piesch S., Dobmeyer J., et al. Genetics of type III hyperlipoproteinemia. Genet Epidemiol 1997, 14:283-297.
15. Coto-Segura P., Coto E., Alvarez V., et al. Apolipoprotein epsilon4 allele is associated with psoriasis severity. Arch Dermatol Res 2010, 302:145-149.
16. Karpouzis A., Caridha R., Tripsianis G., et al. Apolipoprotein E gene polymorphism in psoriasis. Arch Dermatol Res 2009, 301:405-410.
17. Campalani E., Allen M.H., Fairhurst D., et al. Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. Br J Dermatol 2006, 154:345-352.
18. A-H Zhang, L-Q Zhang, G-Q Liu, et al. Investigation of the correlation between apolipoprotein allele 2 and psoriasis vulgaris. Chin J Dermatovenereol 2005, 19:460-462.
19. J-L Wang, E-H Dai, J-Y Wu, et al. Study of the association of apolipoprotein E allelles and blood plasma lipoprotein levels with psoriasis vulgaris. Chin J Dermatovenereol 2001, 15:229-230.
20. Liang Y. The correlation between apolipoprotein E polymorphism and serum lipid in psoriasis vulgaris 2003, Zhong Nan University, 1-16.
21. Patsopoulos N.A., Evangelou E., Ioannidis J.P. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 2008, 37:1148-1157.
22. Corbo R.M., Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?. Ann Hum Genet 1999, 63:301-310.
23. Liang S., Pan M., Geng H.H., et al. Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters. Mol Biol Rep 2009, 36:1251-1256.
24. Breslow J.L. Apolipoprotein genetic variation and human disease. Physiol Rev 1988, 68:85-132.
25. Ewbank D.C. The APOE gene and differences in life expectancy in Europe. J Gerontol A Biol Sci Med Sci 2004, 59:16-20.
26. Hu P., Qin Y.H., Jing C.X., et al. Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations. Mol Biol Rep 2011, 38:489-494.
27. Kuhlmann I., Minihane A.M., Huebbe P., et al. Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis 2010, 9:8.
28. Lucotte G., Loirat F., Hazout S. Pattern of gradient of apolipoprotein E allele 4 frequencies in Western Europe. Hum Biol 1997, 69:253-262.
29. Tiret L., de Knijff P., Menzel H., et al. Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations: the EARS study. Arterioscler Thromb 1994, 14:1617-1624.
30. Singh P.P., Singh M., Mastana S.S. APOE distribution in world populations with new data from India and the UK. Ann Hum Biol 2006, 33:279-308.
31. Ghebranious N., Ivacic L., Mallum J., et al. Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology. Nucleic Acids Res 2005, 33:e149.
32. Song H., Saito K., Fujigaki S., et al. IL-1 beta and TNF-alpha suppress apolipoprotein (apo) E secretion and apo A-I expression in HepG2 cells. Cytokine 1998, 10:275-280.
33. Seishima M., Mori S., Noma A. Serum lipid and apolipoprotein levels in patients with psoriasis. Br J Dermatol 1994, 130:738-742.
34. Grant W.B. A multicountry ecological study of risk-modifying factors for prostate cancer: apolipoprotein E epsilon4 as a risk factor and cereals as a risk reduction factor. Anticancer Res 2010, 30:189-199.
35. Wagner R.D., Krul E.S., Moberly J.B., et al. Apolipoprotein expression and cellular differentiation in Caco-2 intestinal cells. Am J Physiol 1992, 263:E374-E382.
36. Smith E.L., Walworth N.C., Holick M.F. Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986, 86:709-714.
37. Huebbe P., Nebel A., Siegert S., et al. APOE ε4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J 2011, 25:3262-3270.
38. Mathieu A., Cauli A., Vacca A., et al. Genetics of psoriasis and psoriatic arthritis. Reumatismo 2007, 59(suppl 1):S25-S27.
39. Henseler T. The genetics of psoriasis. J Am Acad Dermatol 1997, 37:S1-S11.
40. Lau J., Ioannidis J.P., Terrin N., et al. The case of the misleading funnel plot. BMJ 2006, 333:597-600.